Introducing darunavir-ritonavir would be costly, she said, as ritonavir would have to be bought separately. 她还说,推广darunavir-ritonavir可能很昂贵,因为darunavir需要与ritonavir分开服用。
The common therapeutic drug can be classified into three categories, nucleotide reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor and proteinase inhibitor, among which ritonavir is one of quite effective proteinase inhibitor. 常用的治疗药物有核苷类逆转录酶抑制剂、非核苷类逆转录酶抑制剂和蛋白酶抑制剂等三类。其中利托那韦是十分有效的蛋白酶抑制剂之一。